Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2009-08-21

FDA Approved: ZYFLO — Supplemental Application (Chiesi USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ZYFLO (zileuton) from Chiesi USA, Inc., resulting in a labeling change.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZYFLO (ZILEUTON)

Snippet

SUPPL AP for ZYFLO (ZILEUTON)